Restoring the Bacloville trial: efficacy and harms
Clicks: 263
ID: 268665
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
234 views
29 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Restoring the Bacloville trial: efficacy and harms
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (7 words).
Try re-searching for a better abstract.
| Reference Key |
f2020addictionrestoring
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Naudet F;Braillon A;Cristea IA;Lexchin J;; |
| Journal | addiction (abingdon, england) |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
follow-up studies
comment
letter
alcohol drinking*
outpatients
pmid:32364248
doi:10.1111/add.15109
florian naudet
alain braillon
joel lexchin
baclofen*
gaba-b receptor agonists
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.